AEOL #

Related by string. * : compound AEOL # . Treatment Paradigm AEOL / # [012] . # [007] . # [016] . #s [002] . # [014] . #s [004] . # [004] . # [022] : #.# ov #-# . ID # # . #-#:# pm [001] . i Newswire #-#-# . Call #-#-# [002] . #-#-# ATS [003] . #-#-# ATS [002] . +#-#-#-# [004] * catalytic antioxidant AEOL # . evaluating AEOL # . ROS AEOL # . Stage AEOL # . Applications AEOL # . Specifically AEOL # *

Related by context. Frequent words. (Click for all words.) 68 CBLB# 64 Homspera 61 preclinical studies 59 AP# [003] 59 ISIS # 58 RDEA# 58 bavituximab 58 Phase 1b 58 MGCD# [001] 57 TB4 57 MDV# 57 preclinical 56 HspE7 56 CYT# 56 Phase 2a 56 voreloxin 56 IND enabling 55 Alpharadin 55 CUDC 55 Preclinical studies 55 antitumor activity 55 oritavancin 55 Phase Ib 55 tamibarotene 54 MultiStem 54 HE# [002] 53 vitro studies 53 eculizumab 53 Hollis Eden 53 TNFerade 53 Phase 2a clinical 53 NKTR 53 Phase 2b study 53 pharmacokinetic profile 53 carfilzomib 53 AZD# 53 prodrug 53 preclinical models 53 MGCD# [002] 53 tolerability profile 53 arimoclomol 52 ONCONASE 52 XL# [003] 52 Prochymal 52 INCB# [002] 52 Locteron 52 antiviral activity 52 human monoclonal antibody 52 vivo 52 DAVANAT ® 52 REOLYSIN 52 IDX# 52 Phase IIa 52 humanized monoclonal antibody 52 elesclomol 52 tivozanib 51 ALKS 51 ANA# 51 perifosine 51 bortezomib 51 Phase IIa trial 51 laquinimod 51 oral formulation 51 REOLYSIN R 50 pharmacodynamic 50 dose escalation 50 IMGN# 50 Phase II 50 CK # 50 efficacy 50 FOLOTYN 50 pivotal Phase III 50 APF# 50 BiovaxID 50 Phase III clinical 50 Phase IIb clinical 50 CORLUX 50 LymphoStat B 50 RNAi therapeutic 50 Phase 2b trial 50 Phase IIa clinical 50 therapeutic antibody 50 ENMD 50 RG# [001] 50 ADX# 50 Phase IIb 49 Phase 2b 49 monoclonal antibodies 49 ADVEXIN 49 Stimuvax 49 anticancer 49 pharmacokinetic 49 investigational drug 49 Opexa 49 pivotal Phase 49 PBT2 49 anti angiogenic 49 immunotherapeutic 49 dose escalation study 49 neuroprotective 49 panitumumab

Back to home page